These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6460802)

  • 1. DNA dependence and inhibition by novobiocin and coumermycin of the nucleolar adenosine triphosphatase (ATPase) of human fibroblasts.
    Fox N; Studzinski GP
    J Histochem Cytochem; 1982 Apr; 30(4):364-70. PubMed ID: 6460802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of nucleolar substructure in cultured human fibroblasts by magnesium-activated adenosine triphosphatase reaction.
    Fox N; Fernandez C; Studzinski GP
    J Histochem Cytochem; 1981 Oct; 29(10):1115-20. PubMed ID: 6117591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct inhibition of u.v.-induced DNA excision repair in human cells by novobiocin, coumermycin and nalidixic acid.
    Dresler SL; Robinson-Hill RM
    Carcinogenesis; 1987 Jun; 8(6):813-7. PubMed ID: 3608079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of inhibitors of topoisomerase II and quinacrine on ultraviolet-light-induced DNA incision in normal and xeroderma pigmentosum fibroblasts.
    Thielmann HW; Popanda O; Edler L
    J Cancer Res Clin Oncol; 1991; 117(1):19-26. PubMed ID: 1847700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coumermycin A1 inhibits growth and induces relaxation of supercoiled plasmids in Borrelia burgdorferi, the Lyme disease agent.
    Samuels DS; Garon CF
    Antimicrob Agents Chemother; 1993 Jan; 37(1):46-50. PubMed ID: 8381639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novobiocin inhibits Xenopus transcription factor IIIA-DNA interactions.
    Fiser-Littell RM; Hanas JS
    J Biol Chem; 1987 Sep; 262(25):11916-9. PubMed ID: 2442153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inhibition of vaccinia DNA topoisomerase by novobiocin and coumermycin.
    Sekiguchi J; Stivers JT; Mildvan AS; Shuman S
    J Biol Chem; 1996 Jan; 271(4):2313-22. PubMed ID: 8567695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
    Wu LC; Shahied SI
    Arch Biochem Biophys; 1995 Dec; 324(1):123-9. PubMed ID: 7503546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA gyrase: subunit structure and ATPase activity of the purified enzyme.
    Mizuuchi K; O'Dea MH; Gellert M
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):5960-3. PubMed ID: 153529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancy between the antibacterial activities and the inhibitory effects on Micrococcus luteus DNA gyrase of 13 quinolones.
    Fu KP; Grace ME; McCloud SJ; Gregory FJ; Hung PP
    Chemotherapy; 1986; 32(6):494-8. PubMed ID: 3026740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of novobiocin and other DNA gyrase inhibitors on virus replication and DNA synthesis in herpes simplex virus type 1-infected BHK cells.
    Francke B; Margolin J
    J Gen Virol; 1981 Feb; 52(Pt 2):401-4. PubMed ID: 6270241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
    Hooper DC; Wolfson JS; McHugh GL; Winters MB; Swartz MN
    Antimicrob Agents Chemother; 1982 Oct; 22(4):662-71. PubMed ID: 6295263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy coupling in DNA gyrase and the mechanism of action of novobiocin.
    Sugino A; Higgins NP; Brown PO; Peebles CL; Cozzarelli NR
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4838-42. PubMed ID: 368801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of gene expression in vitro to inhibitors of DNA gyrase.
    Yang HL; Heller K; Gellert M; Zubay G
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3304-8. PubMed ID: 226966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA gyrase activities from Rhodobacter capsulatus: analysis of target(s) of coumarins and cloning of the gyrB locus.
    Kranz RG; Beckman DL; Foster-Hartnett D
    FEMS Microbiol Lett; 1992 May; 72(1):25-32. PubMed ID: 1319375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
    Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ
    Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
    Gellert M; O'Dea MH; Itoh T; Tomizawa J
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4474-8. PubMed ID: 794878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of bacterial DNA gyrase inhibitors on DNA synthesis in mammalian mitochondria.
    Castora FJ; Vissering FF; Simpson MV
    Biochim Biophys Acta; 1983 Sep; 740(4):417-27. PubMed ID: 6309236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.
    Stieger M; Angehrn P; Wohlgensinger B; Gmünder H
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1060-2. PubMed ID: 8849232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of coumarin antibiotics with fragments of DNA gyrase B protein.
    Gormley NA; Orphanides G; Meyer A; Cullis PM; Maxwell A
    Biochemistry; 1996 Apr; 35(15):5083-92. PubMed ID: 8664301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.